Cargando…

Willingness of the General Public to Receive A COVID-19 Vaccine Booster — China, April–May 2021

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? A coronavirus disease 2019 (COVID-19) vaccine booster is planned for administration to eligible individuals. Understanding the factors that influence attitudes towards the booster shot will help to identify groups that will most readily accept a booster dose....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoxiao, Liu, Leyuan, Pei, Minyue, Li, Xiaoguang, Li, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837444/
https://www.ncbi.nlm.nih.gov/pubmed/35186370
http://dx.doi.org/10.46234/ccdcw2022.013
_version_ 1784649910027550720
author Wang, Xiaoxiao
Liu, Leyuan
Pei, Minyue
Li, Xiaoguang
Li, Nan
author_facet Wang, Xiaoxiao
Liu, Leyuan
Pei, Minyue
Li, Xiaoguang
Li, Nan
author_sort Wang, Xiaoxiao
collection PubMed
description WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? A coronavirus disease 2019 (COVID-19) vaccine booster is planned for administration to eligible individuals. Understanding the factors that influence attitudes towards the booster shot will help to identify groups that will most readily accept a booster dose. WHAT IS ADDED BY THIS REPORT? Of the individuals polled, 75.2% reported they would receive a booster shot. Sociodemographic characteristics influencing booster vaccine acceptance included age, gender, occupation, and education. Moreover, those who had been vaccinated against influenza, who believed herd immunity would be effective against severe acute respiratory syndrome coronavirus 2, and who reported reduced anxiety after vaccination were more likely to accept a booster dose. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? A booster shot of the COVID-19 vaccine could be widely accepted. Communicating about the effectiveness of the COVID-19 vaccine and the impact of infection on people’s health could help increase public willingness to get a booster dose.
format Online
Article
Text
id pubmed-8837444
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-88374442022-02-18 Willingness of the General Public to Receive A COVID-19 Vaccine Booster — China, April–May 2021 Wang, Xiaoxiao Liu, Leyuan Pei, Minyue Li, Xiaoguang Li, Nan China CDC Wkly Preplanned Studies WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? A coronavirus disease 2019 (COVID-19) vaccine booster is planned for administration to eligible individuals. Understanding the factors that influence attitudes towards the booster shot will help to identify groups that will most readily accept a booster dose. WHAT IS ADDED BY THIS REPORT? Of the individuals polled, 75.2% reported they would receive a booster shot. Sociodemographic characteristics influencing booster vaccine acceptance included age, gender, occupation, and education. Moreover, those who had been vaccinated against influenza, who believed herd immunity would be effective against severe acute respiratory syndrome coronavirus 2, and who reported reduced anxiety after vaccination were more likely to accept a booster dose. WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE? A booster shot of the COVID-19 vaccine could be widely accepted. Communicating about the effectiveness of the COVID-19 vaccine and the impact of infection on people’s health could help increase public willingness to get a booster dose. Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022-01-28 /pmc/articles/PMC8837444/ /pubmed/35186370 http://dx.doi.org/10.46234/ccdcw2022.013 Text en Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022 https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Preplanned Studies
Wang, Xiaoxiao
Liu, Leyuan
Pei, Minyue
Li, Xiaoguang
Li, Nan
Willingness of the General Public to Receive A COVID-19 Vaccine Booster — China, April–May 2021
title Willingness of the General Public to Receive A COVID-19 Vaccine Booster — China, April–May 2021
title_full Willingness of the General Public to Receive A COVID-19 Vaccine Booster — China, April–May 2021
title_fullStr Willingness of the General Public to Receive A COVID-19 Vaccine Booster — China, April–May 2021
title_full_unstemmed Willingness of the General Public to Receive A COVID-19 Vaccine Booster — China, April–May 2021
title_short Willingness of the General Public to Receive A COVID-19 Vaccine Booster — China, April–May 2021
title_sort willingness of the general public to receive a covid-19 vaccine booster — china, april–may 2021
topic Preplanned Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837444/
https://www.ncbi.nlm.nih.gov/pubmed/35186370
http://dx.doi.org/10.46234/ccdcw2022.013
work_keys_str_mv AT wangxiaoxiao willingnessofthegeneralpublictoreceiveacovid19vaccineboosterchinaaprilmay2021
AT liuleyuan willingnessofthegeneralpublictoreceiveacovid19vaccineboosterchinaaprilmay2021
AT peiminyue willingnessofthegeneralpublictoreceiveacovid19vaccineboosterchinaaprilmay2021
AT lixiaoguang willingnessofthegeneralpublictoreceiveacovid19vaccineboosterchinaaprilmay2021
AT linan willingnessofthegeneralpublictoreceiveacovid19vaccineboosterchinaaprilmay2021